Core Viewpoint - INOVIO Pharmaceuticals is preparing for two major investor conferences in December to showcase its strategic initiatives and engage with investors [1][6] Group 1: Upcoming Conferences - The first conference is the Piper Sandler 37th Annual Healthcare Conference on December 2 in New York, where INOVIO will participate in a fireside chat available via live webcast [2] - The second event is the Oppenheimer Movers in Rare Disease Summit on December 11, where INOVIO will join a panel discussing key near-term catalysts [3] Group 2: Stock Performance - INOVIO's stock price was $1.95 at the time of the Piper Sandler announcement but has decreased to $1.79, reflecting a 5.29% decline [2][3] - The stock has fluctuated between $1.78 and $1.90 on the day of reporting, with a market capitalization of approximately $95.93 million [4] - Over the past year, INOVIO's stock reached a high of $4.61 and a low of $1.30, with a trading volume of 1,073,702 shares on NASDAQ [5]